Cardiovascular
Cerebral Ischemia
7
Pipeline Programs↗
2
Active Trials↗
5
Companies Involved↗
Cerebral ischemia is an early-stage landscape with 7 programs across 5 companies. The most active players are Laboratoire français de Fractionnement et de Biotechnologies, Sanofi, Bayer. 3 therapies are approved with 1 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 1
No programs
Phase 31
Analysis
Trial Status
5
clinical trials
Completed3 · 60%
Recruiting1 · 20%
Not yet recruiting1 · 20%
Clinical Trials
Trial Activity
The Effect of Cilostazol Compared to Aspirin on Endothelial Function in Acute Cerebral Ischemia Patients
Completed·—·Phase 4·NCT03116269·80 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)